Abstract
There is ongoing controversy about potential differences in the influence of the anti-thyroid drugs propylthiouracil (PTU) and methimazole (MMI) on radioiodine treatment of Graves' hyperthyroidism. This retrospective study investigated the influence of PTU and MMI pre-treatment, individually or sequentially, on the outcome of iodine-131 (131I) therapy in 199 patients with Graves' disease who had been treated with 131I for the first time and followed up at 3 and 6 months after treatment. Pre-treatment with PTU, or sequential PTU and MMI pre-treatment, increased the failure rate of 131I therapy and reduced the rate of hypothyroidism. MMI pre-treatment alone had no significant influence on the results of 131I therapy. Logistic regression analyses indicated that PTU pre-treatment and having a thyroid gland of > 60 g were both significantly related to 131I therapy failure.
Get full access to this article
View all access options for this article.
